Nuvectis Pharma Inc (NVCT)

SG&A Expenses

$2.51M

Quarterly · Period ending: · USD

NVCT logo

NVCT SG&A Expenses

Latest reported$2.51M
NVCT Quarterly SG&A Expenses ($23.00K → $2.51M)
High-resolution chart · PNG

NVCT sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuvectis Pharma Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
2,513,000
2,154,000
2,531,000
2,020,000
2,982,000
1,888,000
1,953,000
1,540,000
1,700,000
1,736,000
2,601,000
1,672,000
1,510,000
1,734,000
2,381,000
1,418,000
1,068,000
1,140,000
1,121,000
512,000
1,693,000
23,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.